Primary breast cancer phenotypes associated with propensity for central nervous system metastases

Free article

Comment

Kadri Altundag. Cancer. 2006.

Free article

. 2006 Nov 15;107(10):2521-2; author reply 2522.

doi: 10.1002/cncr.22270.

No abstract available

Comment on

Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R. Tham YL, et al. Cancer. 2006 Aug 15;107(4):696-704. doi: 10.1002/cncr.22041. Cancer. 2006. PMID: 16826579

Possible role of CXCR4-mediated chemotaxis in breast cancer patients with central nervous system metastases.
Altundag K, Morandi P, Altundag O, Gunduz M. Altundag K, et al. Breast Cancer Res Treat. 2005 Feb;89(3):317. doi: 10.1007/s10549-004-2127-9. Breast Cancer Res Treat. 2005. PMID: 15754133 No abstract available.
Brain metastases in breast cancer: prognostic factors and management.
Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB, Kim WK. Lee SS, et al. Breast Cancer Res Treat. 2008 Oct;111(3):523-30. doi: 10.1007/s10549-007-9806-2. Epub 2007 Nov 8. Breast Cancer Res Treat. 2008. PMID: 17990100
Central nervous system metastases in HER-2-overexpressing metastatic breast cancer: a treatment challenge.
Stemmler HJ, Heinemann V. Stemmler HJ, et al. Oncologist. 2008 Jul;13(7):739-50. doi: 10.1634/theoncologist.2008-0052. Epub 2008 Jul 9. Oncologist. 2008. PMID: 18614587 Review.
Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.
Nisticò C, Cuppone F, Bria E, Fornier M, Giannarelli D, Mottolese M, Novelli F, Natoli G, Cognetti F, Terzoli E. Nisticò C, et al. Anticancer Drugs. 2006 Nov;17(10):1193-200. doi: 10.1097/01.cad.0000231485.17063.d3. Anticancer Drugs. 2006. PMID: 17075319
Caring for patients with central nervous system metastases.
Guerrero D. Guerrero D. Nurs Times. 2003 Feb 23-Mar 3;99(8):30-2. Nurs Times. 2003. PMID: 12656020 Review.

Impact of intestinal dysbiosis on breast cancer metastasis and progression.
Zhang J, Xie Q, Huo X, Liu Z, Da M, Yuan M, Zhao Y, Shen G. Zhang J, et al. Front Oncol. 2022 Nov 7;12:1037831. doi: 10.3389/fonc.2022.1037831. eCollection 2022. Front Oncol. 2022. PMID: 36419880 Free PMC article. Review.